Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

While furosemide and other diuretics can help with symptoms, the drugs that have had a very significant impact on the ...

Around 5 million American women have PCOS, which plays into weight, reproductive health, and fertility outcomes. Here's ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

This article is part of a special series investigating the GLP-1 agonist boom. Read more here. A growing number of studies show that semaglutide seems to have many beneficial effects in addition ...

and GLP-1 agonists such as semaglutide (in people with both HFpEF and obesity). These drugs help people lose weight and have also been shown to reduce hospitalization for heart failure.

This article is part of a special series investigating the GLP-1 agonist boom. Read more here. Among the comments, however, you will frequently find reports of other – wholly unexpected ...

“Conversely, inhibition of VTA dopamine neurons reduced consumption.” GLP-1 agonists, including semaglutide, mimic satiety signals in the brain, leading to reduced appetite. These drugs are ...